Table 1 Distribution of the studied cases according to different parameters (n = 20)Â
From: Evaluation of pulmonary complications in patients undergoing allogenic stem cell transplantation
| Â | No. (%) |
|---|---|
Gender (n = 20) | |
 Male | 12 (60%) |
 Female | 8 (40%) |
Original disease (n = 20) | |
 T cell ALL | 4 (20%) |
 B cell ALL | 3 (15%) |
 AML | 13 (65%) |
Symptom (during study) (n = 20) | |
 No | 1 (5%) |
 Yes | 19 (95%) |
 Cough | 14 (70%) |
 Wheezes | 11 (55%) |
 Fever | 1 (5%) |
 Dyspnea | 10 (50%) |
 Sputum | 6 (30%) |
 Cyanosis | 2 (10%) |
 Chest pain | 2 (10%) |
Mortality (n = 20) | |
 No | 19 (95%) |
 Yes (ARDS) | 1 (5%) |